StockData
NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31

Nasus Pharma Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 25, 2026
$3.21+0.02 (+0.79%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

27 of Nasus Pharma's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report6-KOct 8, 2026Oct 8, 2026SEC EDGAR
Current report6-KSep 18, 2026Sep 18, 2026SEC EDGAR
Current report6-KSep 14, 2026Sep 14, 2026SEC EDGAR
Current report6-KSep 4, 2026Sep 4, 2026SEC EDGAR
Current report6-KAug 19, 2026Aug 19, 2026SEC EDGAR
Current report6-KJun 30, 2026Aug 17, 2026SEC EDGAR
Current report6-KJul 28, 2026Jul 28, 2026SEC EDGAR
Current report6-KJun 9, 2026Jun 9, 2026SEC EDGAR
Current report6-KMar 25, 2026Mar 25, 2026SEC EDGAR
Annual report20-FDec 31, 2025Mar 25, 2026SEC EDGAR
Current report6-KMar 16, 2026Mar 16, 2026SEC EDGAR
Current report6-KMar 6, 2026Mar 6, 2026SEC EDGAR
Current report6-KMar 4, 2026Mar 4, 2026SEC EDGAR
Current report6-KFeb 23, 2026Feb 24, 2026SEC EDGAR
Current report6-KFeb 13, 2026Feb 13, 2026SEC EDGAR
Current report6-KFeb 11, 2026Feb 12, 2026SEC EDGAR
Current report6-KJan 29, 2026Jan 29, 2026SEC EDGAR
Current report6-KJan 20, 2026Jan 20, 2026SEC EDGAR
Current report6-KJun 30, 2025Dec 29, 2025SEC EDGAR
Current report6-KDec 22, 2025Dec 22, 2025SEC EDGAR
Current report6-KNov 20, 2025Nov 20, 2025SEC EDGAR
Current report6-KNov 18, 2025Nov 18, 2025SEC EDGAR
Current report6-KNov 3, 2025Nov 3, 2025SEC EDGAR
Current report6-KOct 8, 2025Oct 8, 2025SEC EDGAR
Current report6-KSep 30, 2025Sep 30, 2025SEC EDGAR
Current report6-KSep 5, 2025Sep 5, 2025SEC EDGAR
Current report6-KAug 14, 2025Aug 14, 2025SEC EDGAR